Flurbiprofen inhibits proliferation of thyroid cancer cells by interfering with the interaction between HIP1R and PTEN, thus blocking the endocytosis of PTEN (Fig. 6). This evidence concerns the gene HIP1R and thyroid gland carcinoma.